Ann Neurol 39:147157 Desnuelle C, Dib M, Garrel C, Favier A (2001) A double-blind, placeho-controlled randomized clinical trial of -tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
While benign, the urinary discolouration may interfere with colorimetric laboratory analyses, and may impede intermittent haemodialysis due to the pigment distribution across the dialysate membrane triggering colorimetric blood leak sensors
Combining it with medications that act through different pathways, such as orlistat (which reduces fat absorption) or phentermine (an appetite suppressant with a different mechanism), could theoretically enhance weight loss outcomes by attacking obesity from multiple angles
Potential Benefits Works through amylin receptors rather than GLP-1, offering an alternative pathway for patients who may not respond optimally to GLP-1 medications alone
Targeting GLP-1 receptor trafficking to improve agonist efficacy